Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile
about
An update on antibody-based immunotherapies for Clostridium difficile infectionClostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal EffectsA Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and TraffickingMechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray CrystallographyTranslocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore.A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain AntibodiesMechanisms of Ricin Toxin Neutralization Revealed through Engineered Homodimeric and Heterodimeric Camelid Antibodies.Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.Antibodies for treatment of Clostridium difficile infection.Emerging monoclonal antibodies against Clostridium difficile infection.Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface.Production, crystallization and X-ray diffraction analysis of a complex between a fragment of the TssM T6SS protein and a camelid nanobody.Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody.
P2860
Q26740788-FDBDA468-2F66-45F0-B1C9-748A98A2A861Q26751477-2AED8700-1FB8-473B-BA33-30EA76B4F0C0Q27341563-7E31AA8E-A9DD-4B8B-AB13-D0EB7F75A681Q27683753-2AEF494F-9DBC-408B-8C6A-0469A5B88F79Q34406643-BC3D3675-433E-4E2A-BCE7-476C7AFAC320Q36134100-09E328DC-8852-4662-ABC9-B559C7B7C5B8Q36282935-9AA7FC83-4B54-4C2E-9484-6389D7DDCA17Q37224751-4706F90F-A210-4059-A903-8B88E9A76BECQ38208794-7B87EE9C-3C9C-43C6-915F-04C3AC19C01DQ39168914-F05B5680-3F19-4F1D-BEB7-AC768A8C28FBQ40135481-DFDFA207-2F35-4104-A2D5-7E4EA2C8AD62Q41245882-83D4B682-2A6E-4D49-9161-622392E47C29Q49357853-E2DCC882-B299-416D-8D7D-2DECAED4F18D
P2860
Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Structural Basis for Antibody ...... d B from Clostridium difficile
@ast
Structural Basis for Antibody ...... d B from Clostridium difficile
@en
Structural Basis for Antibody ...... d B from Clostridium difficile
@nl
type
label
Structural Basis for Antibody ...... d B from Clostridium difficile
@ast
Structural Basis for Antibody ...... d B from Clostridium difficile
@en
Structural Basis for Antibody ...... d B from Clostridium difficile
@nl
prefLabel
Structural Basis for Antibody ...... d B from Clostridium difficile
@ast
Structural Basis for Antibody ...... d B from Clostridium difficile
@en
Structural Basis for Antibody ...... d B from Clostridium difficile
@nl
P2093
P2860
P921
P3181
P356
P1476
Structural Basis for Antibody ...... d B from Clostridium difficile
@en
P2093
Elena N Kitova
Greg Hussack
Jamshid Tanha
John S Klassen
Kenneth K S Ng
Luiz Eugenio
Melissa Schorr
Tomohiko Murase
P2860
P304
P3181
P356
10.1074/JBC.M113.505917
P407
P577
2014-01-24T00:00:00Z